Genetic engineering in medicine: paving the way for innovation

Although the development of many innovative drugs and therapies is based on genetic engineering, the term "genetic engineering" regularly meets with resistance. It is often automatically associated with genetically modified plants or foods. For one in four Germans, it evokes negative associations. However, support for genetic engineering rises to 90 percent when respondents are told that genetic engineering can help to better treat diseases such as cancer. But what is actually behind this? more...

Approved genetically engineered drugs in Germany

According to vfa research, 352 biopharmaceuticals with 312 active ingredients produced by genetic engineering are currently approved in Germany. Important areas of application include diabetes (insulins), multiple sclerosis and autoimmune diseases such as rheumatoid arthritis and psoriasis (immunomodulators), cancer (monoclonal antibodies), inborn errors of metabolism and coagulation (enzymes, coagulation factors), as well as protective vaccinations (cervical cancer, hepatitis B) and osteoporosis. more...